Status:
TERMINATED
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Alzheimer's Disease
Eligibility:
MALE
35-65 years
Phase:
PHASE1
Brief Summary
This study is being performed in order to learn more about a new drug (possible as treatment for people with Alzheimer's Disease and other conditions with cognitive dysfunction (memory and attention p...
Eligibility Criteria
Inclusion
- Physically healthy volunteers
- Participation in a previous study for genotyping for identification to be extensive, intermediate or poor metaboliser (CYP2D6 enzyme)
Exclusion
- History of clinically significant diseases or illness.
- Ues of any prescribed or non-prescribed medications from 2 weeks prior to first treatment day except for paracetamol and OTC adrenergic nasal spray.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00777361
Start Date
October 1 2008
End Date
October 1 2009
Last Update
November 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Macclesfield, Cheshire, United Kingdom